Cardiothoracic & vascular anesthesia

Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass

J Cardiothorac Vasc AnesthPublished Observational pre-post study

Main finding · Rate of decline in percentage change in NEeqResult — go to the resultSteeper rate of decline −2.01 % NEeq per 15-minute interval

Authors' conclusion

Implementation of a stepwise protocol using MB, angiotensin II, and hydroxocobalamin for refractory vasoplegia resulted in significant cost savings, hastened NEeq reduction, and similar short-term clinical outcomes.

Study context

Population
Cardiothoracic surgery patients requiring cardiopulmonary bypass (CPB) who received at least one rescue agent (angiotensin II, hydroxocobalamin or MB) perioperatively for refractory vasoplegia (≥0.25 μg/kg/min norepinephrine equivalents (NEeq))
Participants
215 patients
Exposure
Post-protocol vs Pre-protocol
  • Post-protocoln = 96
  • Pre-protocoln = 119reference
Outcome
Rate of decline in percentage change in NEeq
Follow-up
Initial 3 hours
Methodological detailssingle-centre, academic teaching hospital
  • Single-centre
  • Academic teaching hospital

Main finding

As reported in the abstract

Steeper rate of decline

−2.01 % NEeq per 15-minute interval

P < 0.01

Observational data: associations, not effects.

Further findings

Mean NEeq requirement before rescue agent

No difference in mean NEeq requirement preceding rescue agent administration (pre- vs post-protocol, as printed)
0.32 μg/kg/min v 0.31 μg/kg/min

Cost of vasoactive agents (Post-protocol vs Pre-protocol) · 24 hours

Average cost reduction
30%
  • p < 0.01

Cost of vasoactive agents (Post-protocol vs Pre-protocol) · 48 hours

Average cost reduction
26%
  • p < 0.01

Short-term clinical outcomes

No differences between groups

Original publication

Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. Published 6 February 2026. doi:10.1053/j.jvca.2026.02.003

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.